EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Semaglutide, a glucagon-like peptide-1 receptor agonist, inhibits oral squamous cell carcinoma growth through P38 MAPK signaling pathway

Can Wang, Zhengzheng Wu, Jiaying Zhou, Bin Cheng, Yulei Huang

Journal of Cancer Research and Clinical Oncology · 07.03.2025 · 151 (3)

DOI: 10.1007/s00432-025-06154-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 07.03.2025. Verfasst von Can Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, 510055, People's Republic of China. Hauptthemen laut MEDLINE: Glucagon-Like Peptides, Mouth Neoplasms, Carcinoma, Squamous Cell, p38 Mitogen-Activated Protein Kinases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Science and Technology Program of Guangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like PeptidesMouth NeoplasmsCarcinoma, Squamous Cellp38 Mitogen-Activated Protein KinasesGlucagon-Like Peptide-1 Receptor AgonistsMAP Kinase Signaling SystemHumansAnimalsMiceCell ProliferationXenograft Model Antitumor AssaysApoptosisMice, NudeCell Line, TumorCell MovementMaleGlucagon-Like Peptide-1 ReceptorFemaleMice, Inbred BALB CGlucagon-Like Peptide 1Semaglutide

Stichwörter der Autor:innen

GLP-1ROSCCP38 MAPK signaling pathwaySemaglutide

Substanzen

Glucagon-Like Peptidesp38 Mitogen-Activated Protein KinasesGlucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide 1Semaglutide

Autor:innen und Institutionen

  • Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, 510055, People's Republic of China.
  • Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, 510080, People's Republic of China.
  • Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, 510055, People's Republic of China. chengbin@mail.sysu.edu.cn.
  • Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, 510080, People's Republic of China. chengbin@mail.sysu.edu.cn.
  • Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, Guangzhou, 510055, People's Republic of China. huangyulei@mail.sysu.edu.cn.
  • Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, 510080, People's Republic of China. huangyulei@mail.sysu.edu.cn.

Förderung

  • the Science and Technology Program of Guangzhou

Zitieren

APA

Wang, C., Wu, Z., Zhou, J., Cheng, B., & Huang, Y. (2025). Semaglutide, a glucagon-like peptide-1 receptor agonist, inhibits oral squamous cell carcinoma growth through P38 MAPK signaling pathway. Journal of Cancer Research and Clinical Oncology, 151(3). https://doi.org/10.1007/s00432-025-06154-5

Vancouver

Wang C, Wu Z, Zhou J, Cheng B, Huang Y. Semaglutide, a glucagon-like peptide-1 receptor agonist, inhibits oral squamous cell carcinoma growth through P38 MAPK signaling pathway. Journal of Cancer Research and Clinical Oncology. 2025;151(3). doi:10.1007/s00432-025-06154-5

BibTeX
@article{Wang2025,
  author = {Wang, Can and Wu, Zhengzheng and Zhou, Jiaying and Cheng, Bin and Huang, Yulei},
  title = {Semaglutide, a glucagon-like peptide-1 receptor agonist, inhibits oral squamous cell carcinoma growth through P38 MAPK signaling pathway},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2025},
  volume = {151},
  number = {3},
  doi = {10.1007/s00432-025-06154-5}
}
Kostenlos starten →